tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Apogee Therapeutics Reports Promising Trial Results and Strong Cash Position
PremiumCompany AnnouncementsApogee Therapeutics Reports Promising Trial Results and Strong Cash Position
26d ago
Apogee Therapeutics reports Q2 net loss ($66.1M) vs ($33.816M) last year
Premium
The Fly
Apogee Therapeutics reports Q2 net loss ($66.1M) vs ($33.816M) last year
27d ago
Apogee Therapeutics expects cash to fund operations into Q1 of 2028
Premium
The Fly
Apogee Therapeutics expects cash to fund operations into Q1 of 2028
27d ago
Promising Potential of Apogee Therapeutics’ APG777 in Atopic Dermatitis Market Drives Buy Rating and Increased Price Target
PremiumRatingsPromising Potential of Apogee Therapeutics’ APG777 in Atopic Dermatitis Market Drives Buy Rating and Increased Price Target
2M ago
Apogee Therapeutics: Promising Phase 2 Results and Future Growth Potential Justify Buy Rating
Premium
Ratings
Apogee Therapeutics: Promising Phase 2 Results and Future Growth Potential Justify Buy Rating
2M ago
Citi buyers of Apogee Therapeutics on weakness after APG777 data
Premium
The Fly
Citi buyers of Apogee Therapeutics on weakness after APG777 data
2M ago
Apogee Therapeutics Reports Positive Phase 2 Trial Results
PremiumCompany AnnouncementsApogee Therapeutics Reports Positive Phase 2 Trial Results
2M ago
Apogee Therapeutics says APEX Part A met all primary, secondary endpoints
Premium
The Fly
Apogee Therapeutics says APEX Part A met all primary, secondary endpoints
2M ago
3 Best Stocks to Buy Now, 7/3/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/3/2025, According to Top Analysts
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100